PHARMA Market Elements of Growth (MEGR)

Market Elements of GRowth (MEGR)Novartis Egypt market analysis practices

Eng. Walid Saafan (MBA), Business Intelligence Manager

Cairo, Egypt. April/2007

2 | Market Elements of GRowth (MEGR) | Walid Saafan | Apr.07 | Business Use Only

Topics.

Introduction

Product objectives

IMS market elements of growth

Market Elements of Growth (MEGR)

Conclusion


IntroductionStretching IMS data to the edge

IMS DataView limited analysis capabilities

Transform IMS data into a better format for more analysis.

Detailed analysis become easier.

Untapped information are identified and clear.

Techniques can be applied on regional level

“Simple tools with high business impact”

“Charging our knowledge with Extra information”

Simple Market InformationSMI


Product objectives what is the growth driver?

Break down to the market/ CRP elements of growth.

Follow up competitor strategies.

Assess the success of our portfolio management.

Detailed analysis for each element components (NI, LCM, PI).

Assess the leading therapeutic classes in terms of NI/LCM.


IMS Market elements of growthLimited analytical capabilities

IMS produce ‘Market Elements of growth = 5000 US$ per issue, difficult to analyze.


Market Elements of GRowth (MEGR) Think beyond what is possible

Detail analysis for MKT/ MNCs/ OTHERs/ CRPs growth components:

IMS classification:1. New Introductions (new brand was no sales in the previous 5 years).

2. Life Cycle Management (new pack, new strength, new form, etc).

3. Price Increase (price changes granted by MOH – source IMS).

4. Units

5. Others (components that can’t be identified in IMS audits):• Growth due to interaction between simultaneous price and quantity changes- interactive

effect.• Growth due to exchange rate changes• Residual growth :

» Growth caused by discontinued products or packs.» Growth caused by new packs of existing form-strengths.

“Market growth elements at your finger tip”


MEGR data sourcesAll data is available with no extra effort

New Introductions & Life Cycle Management is extracted from IMS Dataview report.

Price Increases reported by IMS, YTD sales impact is calculated accordingly.


Market Elements of GRowth (MEGR)Y06 Market Elements of Growth ‘IMS vs MEGR’

2.2%

18.5%

1.9%0.6%

7%

6.9%

0.0%

2.0%

4.0%

6.0%

8.0%

10.0%

12.0%

14.0%

16.0%

18.0%

20.0%

NIs

LCM P

I

Uni

ts

Oth

ers

GR

%


MEGR - Summary resultsList of all growth elements

List of YTD value for each element along with automated waterfall chart (based on your selection).

Top 30 MNCs

LY Sales NIs # LCM # PI # Y06 sales

Total market 7,864,762,700 175,869,500 145,901,500 46,086,556 9,319,240,304 Top 30 MNCs 3,470,055,600 33,869,200 94,127,400 22,548,675 4,108,206,308 Novartis PH 339,932,900 994,300 41,758,100 4,288,449 411,320,804

Y06 - Value

Others GR%

2.2% 1.9% 0.6% 6.9% 6.9% 18.5%1.0% 2.7% 0.6% 4.1% 10.0% 18.39%0.3% 12.3% 1.3% -5.2% 12.4% 21.00%

PI's UnitsY06 - GR Elements

NIs LCM

Total marketTop 30 MNCsNovartis PH

Select CRP


MEGR - New IntroductionsFull details about NIs

Detailed information including: • CRP, brand, pack(s), PSP, introduction month, YTD value sales.

Selection by CRP/ brand.

NI strategy assessment.

NOVARTIS Y06 NIs

14,040,900

10,405,100

627,3002,014,200

994,300

-

2,000,000

4,000,000

6,000,000

8,000,000

10,000,000

12,000,000

14,000,000

16,000,000

FLO

TA

C

HY

PO

TE

AR

S

AN

TO

PR

AL

MIA

CA

LCIC

PLU

S

TO

TA

L N

Is


MEGR - Life Cycle Management LCMFull details about LCMs

Detailed information including: • CRP, brand, pack(s), PSP, introduction month, YTD value sales.



NOVARTIS LCM-Y06

41,841,300

10,405,100

627,300579,20083,2006,843,000

4,304,300

14,392,400

4,606,800

-

5,000,000

10,000,000

15,000,000

20,000,000

25,000,000

30,000,000

35,000,000

40,000,000

45,000,000

FL

OT

AC

(JA

N)

AN

AF

RO

NIL

75

mg

20

T(F

EB

)

CA

TA

FL

AM

50

mg

20

T(F

EB

)

CA

TA

FL

AM

75

mg

6A

MP

(AP

R)

VO

LT

AR

EN

75

mg

6A

MP

(AP

R)

CH

(JU

L)

SIR

DA

LU

D2

MG

20

T(J

UL

)

MIA

CA

LC

ICP

LU

S (

SE

P)

To

tal


MEGR - Price Increases PI Full details about PIs

Detailed information including: • CRP, brand, pack(s), old/ new price, monthly PI sales impact.



NOVARTIS PIs -Y06

4,775,380

1,964,285

1,453,241

870,923

486,931

-

1,000,000

2,000,000

3,000,000

4,000,000

5,000,000

6,000,000

CO

-TA

RE

G

PR

OC

TO

GLY

VE

NO

L

TA

RE

G

VO

LTA

RE

N

TO

TA

L


ConclusionInformation is a competitive edge

Local tools transfers IMS data into new information for detailed analysis and identify untapped opportunities.

Identification of the growth drivers for competitors is important to follow up our performance in the market.


Thank you.

PHARMA Market Elements of Growth (MEGR)

Health & Medicine

Transcript of PHARMA Market Elements of Growth (MEGR)